Cytek Biosciences, Inc.
CTKB
$4.27
-$0.09-2.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 261.53M | 261.73M | 262.02M | 265.61M | 277.86M |
| Total Receivables | 72.13M | 61.67M | 56.67M | 55.21M | 60.59M |
| Inventory | 48.66M | 51.91M | 49.94M | 45.65M | 44.01M |
| Prepaid Expenses | 6.90M | 2.85M | 4.03M | 4.37M | 6.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.79M | 10.32M | 10.17M | 9.67M | 7.41M |
| Total Current Assets | 392.00M | 388.49M | 382.83M | 380.50M | 396.45M |
|
|
|||||
| Total Current Assets | 392.00M | 388.49M | 382.83M | 380.50M | 396.45M |
| Net Property, Plant & Equipment | 29.32M | 29.20M | 34.74M | 27.70M | 28.13M |
| Long-term Investments | 16.70M | 16.70M | 16.71M | 16.68M | 16.66M |
| Goodwill | 16.70M | 16.70M | 16.71M | 16.68M | 16.66M |
| Total Other Intangibles | 16.82M | 17.68M | 18.60M | 19.43M | 20.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.10M | 41.25M | 38.85M | 36.68M | 38.13M |
| Total Assets | 461.54M | 494.92M | 493.32M | 482.60M | 499.50M |
|
|
|||||
| Total Accounts Payable | 6.41M | 7.63M | 6.85M | 6.25M | 5.53M |
| Total Accrued Expenses | 25.18M | 21.68M | 22.12M | 19.75M | 21.69M |
| Short-term Debt | 600.00K | 600.00K | 1.40M | 2.40M | 4.16M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.58M | 10.08M | 7.37M | 5.13M | 8.41M |
| Total Finance Division Other Current Liabilities | 37.04M | 35.22M | 35.53M | 34.16M | 32.03M |
| Total Other Current Liabilities | 37.04M | 35.22M | 35.53M | 34.16M | 32.03M |
| Total Current Liabilities | 77.80M | 75.21M | 73.27M | 67.69M | 67.66M |
|
|
|||||
| Total Current Liabilities | 77.80M | 75.21M | 73.27M | 67.69M | 67.66M |
| Long-Term Debt | 525.00K | 655.00K | 791.00K | 918.00K | 1.05M |
| Short-term Debt | 600.00K | 600.00K | 1.40M | 2.40M | 4.16M |
| Capital Leases | 14.04M | 13.49M | 14.12M | 7.45M | 7.55M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.43M | 26.99M | 27.58M | 26.92M | 27.50M |
| Total Liabilities | 119.80M | 116.35M | 115.76M | 102.97M | 103.76M |
|
|
|||||
| Common Stock & APIC | 441.24M | 435.41M | 429.78M | 426.83M | 430.92M |
| Retained Earnings | -101.74M | -57.66M | -52.18M | -46.60M | -35.20M |
| Treasury Stock & Other | 2.24M | 821.00K | -38.00K | -609.00K | 16.00K |
| Total Common Equity | 341.74M | 378.57M | 377.56M | 379.62M | 395.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 341.74M | 378.57M | 377.56M | 379.62M | 395.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 341.74M | 378.57M | 377.56M | 379.62M | 395.74M |
|
|
|||||